Table 3.
Incidence rates (per 100,000) of microscopically verified lung cancer by histological type
| Males
|
Females
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Country or area of registry/ethnicity | SCC | AC | LCC | SCLC | AC/SCC ratio | SCC | AC | LCC | SCLC | AC/SCC ratio |
| Australia | 6.7 | 9.5 | 4.7 | 3.8 | 1.4 | 0.6 | 0.4 | 0.3 | 0.0 | 0.7 |
| Belgium | 19.2 | 18.4 | 3.8 | 9.0 | 1.0 | 2.8 | 8.0 | 1.0 | 3.0 | 2.9 |
| Belarus | 26.9 | 5.8 | 1.7 | 6.4 | 0.2 | 1.1 | 1.4 | 0.1 | 0.3 | 1.3 |
| Brazil | 4.1 | 5.9 | 3.9 | 1.4 | 1.4 | 1.2 | 3.1 | 1.6 | 0.8 | 2.8 |
| Canada | 9.5 | 11.9 | 3.7 | 5.0 | 1.3 | 3.9 | 11.8 | 2.5 | 4.0 | 3.0 |
| China | 6.5 | 9.3 | 1.3 | 2.6 | 1.4 | 1.1 | 7.1 | 0.6 | 0.6 | 6.6 |
| China, Beijing City | 8.3 | 9.4 | 2.2 | 3.8 | 1.1 | 1.7 | 8.6 | 1.2 | 1.2 | 5.1 |
| China, Nangang District, Harbin City | 2.2 | 1.2 | – | 1.2 | 0.5 | 0.4 | 0.8 | – | 0.3 | 2.0 |
| China, Shanghai City | 6.3 | 8.2 | 0.2 | 1.4 | 1.3 | 0.7 | 7.1 | 0.1 | 0.2 | 10.1 |
| China, Cixian County | 15.4 | 20.7 | – | 3.5 | 1.3 | 7.1 | 9.5 | – | 1.1 | 1.3 |
| China, Hong Kong | 9.9 | 19.1 | 1.5 | 4.5 | 1.9 | 1.3 | 12.6 | 0.5 | 0.6 | 9.7 |
| Egypt, Gharbiah | 2.2 | 2.9 | 3.0 | 1.4 | 1.3 | 0.3 | 1.5 | 0.7 | 0.2 | 5.0 |
| India | 1.6 | 1.4 | 2.1 | 1.0 | 0.9 | 0.4 | 0.8 | 0.7 | 0.3 | 2.1 |
| India, Bangalore | 0.9 | 1.8 | 2.0 | 0.7 | 2.0 | 0.2 | 0.8 | 0.8 | 0.2 | 4.0 |
| India, Chennai | 2.2 | 1.9 | 2.4 | 0.5 | 0.9 | 0.3 | 0.8 | 0.7 | 0.1 | 2.7 |
| India, Mumbai | 1.4 | 2.2 | 0.7 | 1.3 | 1.6 | 0.3 | 1.1 | 0.2 | 0.4 | 3.7 |
| India, New Delhi | 1.8 | 0.8 | 4.4 | 1.1 | 0.4 | 0.3 | 0.4 | 1.1 | 0.2 | 1.3 |
| Japan | 9.1 | 14.9 | 1.8 | 4.3 | 1.6 | 1.0 | 8.7 | 0.3 | 0.7 | 8.7 |
| The Netherlands | 13.3 | 11.8 | 8.3 | 7.3 | 0.9 | 3.5 | 8.1 | 4.3 | 4.8 | 2.3 |
| Russia | 15.6 | 4.0 | 1.6 | 4.7 | 0.3 | 1.3 | 1.4 | 0.2 | 0.6 | 1.1 |
| Saudi Arabia | 1.1 | 2.2 | 0.7 | 0.6 | 2.1 | 0.2 | 1.3 | 0.0 | 0.0 | 6.2 |
| Sweden | 5.1 | 7.1 | 4.5 | 2.5 | 1.4 | 2.5 | 7.6 | 3.4 | 2.2 | 3.0 |
| Tunisia, North | 7.8 | 4.9 | 8.2 | 3.8 | 0.6 | 0.4 | 0.6 | 0.8 | 0.2 | 1.5 |
| Thailand | 3.6 | 8.1 | 2.1 | 1.5 | 2.2 | 1.1 | 4.4 | 0.9 | 0.5 | 4.0 |
| Uruguay | 8.6 | 8.5 | 5.8 | 3.4 | 1.0 | 1.1 | 2.5 | 1.0 | 0.8 | 2.3 |
| United States | ||||||||||
| US, American Indian | 8.9 | 7.9 | 1.9 | 4.8 | 0.9 | 4.6 | 7.6 | 1.2 | 4.9 | 1.7 |
| US, Asian & Pacific Islander | 4.3 | 10.3 | 1.5 | 2.3 | 2.4 | 1.3 | 8.4 | 0.8 | 0.9 | 6.5 |
| US, Black | 15.8 | 18.4 | 4.2 | 6.0 | 1.2 | 5.8 | 11.8 | 1.9 | 3.9 | 2.0 |
| US, White | 11.6 | 14.3 | 2.9 | 7.0 | 1.2 | 5.4 | 12.6 | 1.8 | 6.0 | 2.3 |
SCC, squamous cell carcinoma; AC, adenocarcinoma; LCC, large cell carcinoma; SCLC, small cell lung cancer
Data sources: Cancer Incidence in Five Continents Volume X (2003–2007).15
Notes: 1. Rates age-standardized to the world standard population.
2. Italicized names indicate <60% of cases were microscopically verified. Exact percentages were 59.1%, 55.4% and 54.7% for China, Russia and Thailand, respectively.
3. China includes data from the 14 available cancer registries in China.
4. India includes data from the 12 available cancer registries in India.